rs201012268
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001807.6(CEL):c.1619G>A(p.Arg540His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000897 in 1,609,546 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001807.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEL | NM_001807.6 | c.1619G>A | p.Arg540His | missense_variant | 11/11 | ENST00000372080.8 | NP_001798.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEL | ENST00000372080.8 | c.1619G>A | p.Arg540His | missense_variant | 11/11 | 5 | NM_001807.6 | ENSP00000361151 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00456 AC: 693AN: 151872Hom.: 7 Cov.: 31
GnomAD3 exomes AF: 0.00116 AC: 280AN: 241210Hom.: 2 AF XY: 0.000894 AC XY: 118AN XY: 131932
GnomAD4 exome AF: 0.000510 AC: 744AN: 1457558Hom.: 7 Cov.: 34 AF XY: 0.000451 AC XY: 327AN XY: 725300
GnomAD4 genome AF: 0.00460 AC: 699AN: 151988Hom.: 7 Cov.: 31 AF XY: 0.00472 AC XY: 351AN XY: 74300
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 30, 2019 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Dec 21, 2018 | ACMG criteria: BA1 (1.6% MAF in gnomAD Africans)=benign (REVEL 0.161 + BP4/9 predictors= conflicting evidence, not using) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at